Ergenekon KARAGÖZ, Veysel ÖZALPER, Asım ÜLÇAY, Yalçın ÖNEM, Cihan TOP

Coagulopathy Induced by Cefoperazone/Sulbactam in a Geriatric Patient

Cefoperazone, which is a third generation cephalosporin, has a broad spectrum activity. In clinical studies, only a few adverse effects of this agent have been reported, and these effects are similar to those seen with other cephalosporins. An 86 year-old man was admitted to emergency department with complaints of high fever, cough and weakness. On his physical examination; the patient was alert and had a limited orientation, as well as a reduced general condition. After our investigations, the coagulation disorder was bonded with C/S treatment and we stopped administration of Cefoperazone/Sulbactam(C/S). The bleeding was controlled with intravenous vitamin K and fresh frozen plasma and coagulation tests were recovered to normal values. His antibiotherapy was changed with meropenem. Unfortunately, the patient died due to the progression of respiratory and renal failure. In conclusion, the clinician should keep in mind this complication while administrating this agent. Therefore, close follow-up of coagulation parameters is crucial.

PDF

___

1. Obata H, Iizuka B, Uchida K. Pathogenesis of hypoprothrombinemia induced by antibiotics. J NutrSciVitaminol (Tokyo). 1992:421-4.

2. Huilgol VR, Markus SL, Vakil NB. Antibiotic-induced iatrogenic hemobilia. Am J Gastroenterol. 1997;92(4):706-7.

3. Narumi S, Sasaki M, Okudera D, Tann E, Konn M. Postoperative abnormal prothrombinemia in patients with cefoperazone: Report of two cases. Surg Today. 1998;28(2):227-30.

4. Matsubara T, Touchi A, Harauchi T, Takano K, Yoshizaki T. Depression of liver microsomal vitamin K epoxide reductase activity associated with antibiotic-induced coagulopathy. Biochem Pharmacol. 1989;38(16):2693-701.

5. Wong RS, Cheng G, Chan NP, Wong WS, NG MH. Use of cefoperazone still needs a caution for bleeding from induced vitamin K deficiency. Am J Hematol. 2006;81(1): 76.

6. Alagozlu H, Cindoruk M, Unal S. Severe INR elevation in a patient with choledocholithiasis receiving cefoperazone. Clin Drug Investig. 2006;26(8):481-4 . 7. Cilan H, Ünal A, Sipahioğlu MH, Coşkun R, Tokgöz B, Oymak O, Utaş C. Cephapeazone-sulbactam induced coagulopathy in a peritoneal dialysis patient. Turkish Neph Dia and Trans Journal. 2010;19(1):59-61.

8. Burgess E. Intraperitonealcefoperazone treatment resulting in coagulation abnormality. Perit Dial Int. 1990;10(2):180-1.

9. Sattler FR, Colao DJ, Caputo GM, Schoolwerth AC. Cefoperazone for empiric therapy in patients with impaired renal function. Am J Med. 1986;81(2):229-36.

10. Rockoff SD, Blumenfrucht MJ, Irwin RJ, Eng RH. Vitamin K supplementation during prophylactic use of cefoperazone in urologic surgery. Infection. 1992;20(3):146-8.